Race and Inflammatory Bowel Disease in an Urban Healthcare System
Inflammatory bowel disease (IBD) is increasingly common among non-Caucasian populations, but interracial differences in disease characteristics and management are not well-characterized.
We tested the hypothesis that disease characteristics and management vary by race among IBD patients in an ethnically diverse healthcare system.
A retrospective study of the safety net healthcare system of San Francisco, CA, from 1996 to 2009 was undertaken. Patient records with International Classification of Diseases, 9th Revision (ICD9) codes 555.xx, 556.xx, and 558.xx were reviewed. Adult patients with confirmed IBD diagnoses were included. Interracial variations in disease characteristics and management were assessed broadly; focused between-race comparisons identified specific differences.
The 228 subjects included 77 (33.4%) with Crohn’s disease (CD), 150 (65.8%) with ulcerative colitis, and 1 (0.4%) with IBD, type unclassified. The race distribution included 105 (46.1%) white, 34 (14.9%) black, 35 (15.4%) Hispanic, and 51 (22.4%) Asian subjects. Asians and Hispanics were diagnosed at older ages (41.0 and 37.1 years, respectively) and had shorter disease durations (5.4 and 5.2 years, respectively) than whites (30.5 years at diagnosis and 8.6 years duration, P < 0.05) and blacks (31.7 years at diagnosis and 12.1 years duration, P < 0.05). CD was more common among blacks (50% of subjects) than Asians (25.5% of subjects, P = 0.015). The Montreal classification of IBD was similar among races. Hispanics were less likely than others to be treated with 5-aminosalicylates (5-ASA), immunomodulators, and steroids. Medical and surgical management was otherwise similar among races.
Modest race-based differences in IBD characteristics exist in this racially diverse healthcare system, but the management of IBD is similar among race groups.
- Lok KH, Hung HG, Ng CH, et al. Epidemiology and clinical characteristics of ulcerative colitis in Chinese population: experience from a single center in Hong Kong. J Gastroenterol Hepatol. 2008;23:406–410. CrossRef
- Leong RW, Lau JY, Sung JJ. The epidemiology and phenotype of Crohn’s disease in the Chinese population. Inflamm Bowel Dis. 2004;10:646–651. CrossRef
- Yang SK, Yun S, Kim JH, et al. Epidemiology of inflammatory bowel disease in the Songpa-Kangdong district, Seoul, Korea, 1986–2005: a KASID study. Inflamm Bowel Dis. 2008;14:542–549. CrossRef
- Victoria CR, Sassak LY, Nunes HR. Incidence and prevalence rates of inflammatory bowel diseases, in midwestern of São Paulo State, Brazil. Arq Gastroenterol. 2009;46:20–25. CrossRef
- Lok KH, Hung HG, Ng CH, et al. The epidemiology and clinical characteristics of Crohn’s disease in the Hong Kong Chinese population: experiences from a regional hospital. Hong Kong Med J. 2007;13:436–441.
- Chow DK, Leong RW, Tsoi KK, et al. Long-term follow-up of ulcerative colitis in the Chinese population. Am J Gastroenterol. 2009;104:647–654. CrossRef
- Yoshida Y, Murata Y. Inflammatory bowel disease in Japan: studies of epidemiology and etiopathogenesis. Med Clin North Am. 1990;74:67–90.
- Loftus EV Jr. Clinical epidemiology of inflammatory bowel disease: incidence, prevalence, and environmental influences. Gastroenterology. 2004;126:1504–1517. CrossRef
- Sewell JL, Yee HF Jr, Inadomi JM. Hospitalizations are increasing among minority patients with Crohn’s disease and ulcerative colitis. Inflamm Bowel Dis. 2010;16:204–207.
- Samimi R, Flasar MH, Kavic S, et al. Outcome of medical treatment of stricturing and penetrating Crohn’s disease: a retrospective study. Inflamm Bowel Dis. 2010;16:1187–1194.
- Portela F, Magro F, Lago P, et al. Ulcerative colitis in a Southern European country: a national perspective. Inflamm Bowel Dis. 2010;16:822–829. CrossRef
- Basu D, Lopez I, Kulkarni A, et al. Impact of race and ethnicity on inflammatory bowel disease. Am J Gastroenterol. 2005;100:2254–2261. CrossRef
- Nguyen GC, Torres EA, Regueiro M, et al. Inflammatory bowel disease characteristics among African Americans, Hispanics, and non-Hispanic Whites: characterization of a large North American cohort. Am J Gastroenterol. 2006;101:1012–1023. CrossRef
- Bindman AB, Chen A, Fraser JS, et al. Healthcare reform with a safety net: lessons from San Francisco. Am J Manag Care. 2009;15:747–750.
- University of California San Francisco (UCSF) School of Medicine—San Francisco General Hospital. Facts and figures. Available online at: http://www.medschool.ucsf.edu/sfgh/facts-figures. Accessed March 15, 2010.
- McWilliams JM, Meara E, Zaslavsky AM, et al. Differences in control of cardiovascular disease and diabetes by race, ethnicity, and education: U.S. trends from 1999 to 2006 and effects of Medicare coverage. Ann Intern Med. 2009;150:505–515.
- Moylan CA, Brady CW, Johnson JL, et al. Disparities in liver transplantation before and after introduction of the MELD score. JAMA. 2008;300:2371–2378. CrossRef
- U.S. Census Bureau. State and county quick facts for San Francisco, CA, 2008. Available online at: http://quickfacts.census.gov/qfd/states/06/06075.html. Accessed March 15, 2010.
- Sewell JL, Kushel MB, Inadomi JM, et al. Non-English speakers attend gastroenterology clinic appointments at higher rates than English speakers in a vulnerable patient population. J Clin Gastroenterol. 2009;43:652–660. CrossRef
- Chen AH, Kushel MB, Grumbach K, et al. Practice profile. A safety-net system gains efficiencies through ‘eReferrals’ to specialists. Health Aff (Millwood). 2010;29:969–971. CrossRef
- Satsangi J, Silverberg MS, Vermeire S, et al. The Montreal classification of inflammatory bowel disease: controversies, consensus, and implications. Gut. 2006;55:749–753. CrossRef
- Winker MA. Measuring race and ethnicity: why and how? JAMA. 2004;292:1612–1614. CrossRef
- Tsironi E, Feakins RM, Probert CS, et al. Incidence of inflammatory bowel disease is rising and abdominal tuberculosis is falling in Bangladeshis in East London, United Kingdom. Am J Gastroenterol. 2004;99:1749–1755. CrossRef
- Cosnes J. Can we modulate the clinical course of inflammatory bowel diseases by our current treatment strategies? Dig Dis. 2009;27:516–521. CrossRef
- Dassopoulos T, Nguyen GC, Talor MV, et al. NOD2 mutations and anti-Saccharomyces cerevisiae antibodies are risk factors for Crohn’s disease in African Americans. Am J Gastroenterol. 2010;105:378–386. CrossRef
- Kugathasan S, Loizides A, Babusukumar U, et al. Comparative phenotypic and CARD15 mutational analysis among African American, Hispanic, and White children with Crohn’s disease. Inflamm Bowel Dis. 2005;11:631–638. CrossRef
- Inoue N, Tamura K, Kinouchi Y, et al. Lack of common NOD2 variants in Japanese patients with Crohn’s disease. Gastroenterology. 2002;123:86–91. CrossRef
- Yamazaki K, Takahashi A, Takazoe M, et al. Positive association of genetic variants in the upstream region of NKX2–3 with Crohn’s disease in Japanese patients. Gut. 2009;58:228–232. CrossRef
- Tanaka M, Arimura Y, Goto A, et al. Genetic variants in surfactant, pulmonary-associated protein D (SFTPD) and Japanese susceptibility to ulcerative colitis. Inflamm Bowel Dis. 2009;15:918–925. CrossRef
- Zhang HF, Qiu LX, Chen Y, et al. ATG16L1 T300A polymorphism and Crohn’s disease susceptibility: evidence from 13,022 cases and 17,532 controls. Hum Genet. 2009;125:627–631. CrossRef
- Flasar MH, Johnson T, Roghmann MC, et al. Disparities in the use of immunomodulators and biologics for the treatment of inflammatory bowel disease: a retrospective cohort study. Inflamm Bowel Dis. 2008;14:13–19. CrossRef
- Herrinton LJ, Liu L, Fireman B, et al. Time trends in therapies and outcomes for adult inflammatory bowel disease, Northern California, 1998–2005. Gastroenterology. 2009;137:502–511. CrossRef
- Farrokhyar F, McHugh K, Irvine EJ. Self-reported awareness and use of the International Classification of Diseases coding of inflammatory bowel disease services by Ontario physicians. Can J Gastroenterol. 2002;16:519–526.
- Race and Inflammatory Bowel Disease in an Urban Healthcare System
- Open Access
- Available under Open Access This content is freely available online to anyone, anywhere at any time.
Digestive Diseases and Sciences
Volume 55, Issue 12 , pp 3479-3487
- Cover Date
- Print ISSN
- Online ISSN
- Springer US
- Additional Links
- Inflammatory bowel diseases
- Colitis, ulcerative
- Crohn’s disease
- Ethnic groups
- Health status disparities
- Industry Sectors
- Author Affiliations
- 1. Center for Innovation in Access and Quality, Division of Gastroenterology and Hepatology, San Francisco General Hospital, Department of Medicine, University of California San Francisco, 1001 Potrero Avenue, SFGH NH-3D7, GI Unit, San Francisco, CA, 94110, USA
- 2. Division of Gastroenterology and Hepatology, Department of Medicine, University of Washington, Seattle, WA, USA